Thus, the inhibition of RANKL signaling by IFN-γ can be a promising approach toward the prevention of osteoclastic bone resorption, and the prospects of using IFN-γ to treat bone cancer metastasis have already been reported41. This evidence concerns the gene IFNG and bone cancer.